Hot Debate: Complement Inhibition vs Nefecon in IgA Nephropathy – Which First for Patients at Risk?

29 Mar 2026 3:50 p.m. 4:50 p.m.

Main Hall

Time	Session

3:45 p.m. 4:05 p.m.	Complement inhibition should be considered before nefecon in patients with IgAN at risk of progression
4:05 p.m. 4:25 p.m.	Nefecon should be considered before complement inhibition in patients with IgAN at risk of progression